MedCity News
MAY 21, 2023
Krystal Biotech’s Vyjuvek is approved to treat recessive and dominant forms of dystrophic epidermolysis bullosa (DEB), a rare genetic skin disorder. The redosable gene therapy, applied to the skin, delivers a gene that gets cells to produce collagen that DEB patients lack.
MedCity News
MAY 21, 2023
Moon Surgical recently raised $55.5 million for its robotic surgical assistant, which has earned regulatory clearance in the U.S. and European Union. The startup also appointed Fred Moll, founder of Intuitive Surgical and Auris Health, as independent chair of its board.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
MAY 21, 2023
Individual market insurers are estimated to owe about $500 million in rebates to enrollees this year, a Kaiser Family Foundation analysis found. Small group market insurers are anticipated to owe about $330 million, and large group market insurers are expected to owe about $250 million.
MedCity News
MAY 21, 2023
The MedCity INVEST conference included a panel discussion on raising public venture capital in Canada, sponsored by Cozen O’Connor and TSX.
Expert insights. Personalized for you.
110 
Let's personalize your content